Fineotex Chemical Secures ₹342.5 Crore Funding Boost Through Equity and Warrant Allotment

Fineotex Chemical Limited (Fineotex), a leading specialty chemical manufacturer, has successfully raised ₹342.5 crores through a preferential allotment of equity shares and convertible warrants. This strategic move strengthens the company’s financial position and fuels future growth.

Multi-Phased Fundraising

The fund-raising was executed in two distinct phases:

Phase I:

• Equity Allotment: 9,70,000 shares issued at ₹346 per share, totalling ₹33.56 crores.
• Warrant Allotment: 26,26,600 warrants issued at ₹346 per warrant, totaling ₹90.88 crore.
• Upfront Payment Received: ₹22.72 crore, representing 25% of the total warrant issue size.
• Warrant Conversion: Each warrant is convertible into one equity share upon payment of the remaining 75% (₹259.50 per warrant) within 18 months of issuance.

Phase II:

• Equity Allotment: 28,15,049 shares issued at ₹387.40 per share, totaling ₹109.05 crore.
• Warrant Allotment: 28,15,049 warrants issued at ₹387.40 per warrant, totalling ₹109.05 crores.
• Upfront Payment Received: ₹27.26 crore, representing 25% of the total warrant issue size.
• Warrant Conversion: Each warrant is convertible into one equity share upon payment of the remaining 75% (₹290.55 per warrant) within 18 months of issuance.

Benefits

• Enhance Financial Strength: The additional capital bolsters Fineotex’s financial position, enabling it to pursue future growth initiatives.
• Unlock Investment Potential: The convertible warrants offer investors the potential for capital appreciation if the company’s stock price increases significantly within the conversion period.

Commenting on the fund raise, Mr Sanjay Tibrewala, CFO and Executive Director of Fineotex Chemical, said: “This preferential allotment aligns with the initial tranche of our fund raising on May 22, 2024, amounting to ₹124.4 crore. The cumulative funds raised from both tranches now total ₹342.6 crore. As of July 22, 2024, Fineotex has received ₹192.6 crore equity allotment and warrant subscriptions. The capital raised will be invested strategically to support both organic and inorganic growth opportunities, reinforcing our commitment to enhancing shareholder value and advancing operational excellence.”

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. It is based on several secondary sources on the internet and is subject to changes. Please consult an expert before making related decisions.